Literature DB >> 30844405

Comparison of RNA Editing Activity of APOBEC1-A1CF and APOBEC1-RBM47 Complexes Reconstituted in HEK293T Cells.

Aaron D Wolfe1, Don B Arnold2, Xiaojiang S Chen3.   

Abstract

RNA editing is an important form of regulating gene expression and activity. APOBEC1 cytosine deaminase was initially characterized as pairing with a cofactor, A1CF, to form an active RNA editing complex that specifically targets APOB RNA in regulating lipid metabolism. Recent studies revealed that APOBEC1 may be involved in editing other potential RNA targets in a tissue-specific manner, and another protein, RBM47, appears to instead be the main cofactor of APOBEC1 for editing APOB RNA. In this report, by expressing APOBEC1 with either A1CF or RBM47 from human or mouse in an HEK293T cell line with no intrinsic APOBEC1/A1CF/RBM47 expression, we have compared direct RNA editing activity on several known cellular target RNAs. By using a sensitive cell-based fluorescence assay that enables comparative quantification of RNA editing through subcellular localization changes of eGFP, the two APOBEC1 cofactors, A1CF and RBM47, showed clear differences for editing activity on APOB and several other tested RNAs, and clear differences were observed when mouse versus human genes were tested. In addition, we have determined the minimal domain requirement of RBM47 needed for activity. These results provide useful functional characterization of RBM47 and direct biochemical evidence for the differential editing selectivity on a number of RNA targets.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  APOBEC1; RNA editing; cell-based RNA editing assay; cofactor A1CF and RBM47

Mesh:

Substances:

Year:  2019        PMID: 30844405      PMCID: PMC6443457          DOI: 10.1016/j.jmb.2019.02.025

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  53 in total

1.  A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals.

Authors:  B R Henderson; A Eleftheriou
Journal:  Exp Cell Res       Date:  2000-04-10       Impact factor: 3.905

Review 2.  Retroviral restriction by APOBEC proteins.

Authors:  Reuben S Harris; Mark T Liddament
Journal:  Nat Rev Immunol       Date:  2004-11       Impact factor: 53.106

3.  C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.

Authors:  Debnath Mukhopadhyay; Shrikant Anant; Robert M Lee; Susan Kennedy; David Viskochil; Nicholas O Davidson
Journal:  Am J Hum Genet       Date:  2001-11-27       Impact factor: 11.025

4.  Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). structure-function relationships of RNA editing and dimerization.

Authors:  B B Teng; S Ochsner; Q Zhang; K V Soman; P P Lau; L Chan
Journal:  J Lipid Res       Date:  1999-04       Impact factor: 5.922

5.  Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity.

Authors:  V Blanc; J O Henderson; S Kennedy; N O Davidson
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

6.  Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex.

Authors:  H Lellek; R Kirsten; I Diehl; F Apostel; F Buck; J Greeve
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

Review 7.  Identification and regulation of protein components of the apolipoprotein B mRNA editing enzyme. A complex event.

Authors:  Shrikant Anant; Nicholas O Davidson
Journal:  Trends Cardiovasc Med       Date:  2002-10       Impact factor: 6.677

8.  Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.

Authors:  Anuradha Mehta; Donna M Driscoll
Journal:  RNA       Date:  2002-01       Impact factor: 4.942

9.  The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay.

Authors:  Ann Chester; Angelika Somasekaram; Maria Tzimina; Adam Jarmuz; Jane Gisbourne; Raymond O'Keefe; James Scott; Naveenan Navaratnam
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

10.  Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure.

Authors:  David H Mathews; Matthew D Disney; Jessica L Childs; Susan J Schroeder; Michael Zuker; Douglas H Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

View more
  8 in total

Review 1.  RNA binding motif 47 (RBM47): emerging roles in vertebrate development, RNA editing and cancer.

Authors:  Pavan Kumar Mysuru Shivalingappa; Vaishali Sharma; Anjali Shiras; Sharmila A Bapat
Journal:  Mol Cell Biochem       Date:  2021-09-09       Impact factor: 3.396

2.  APOBEC1 mediated C-to-U RNA editing: target sequence and trans-acting factor contribution to 177 RNA editing events in 119 murine transcripts in-vivo.

Authors:  Saeed Soleymanjahi; Valerie Blanc; Nicholas Davidson
Journal:  RNA       Date:  2021-06-03       Impact factor: 5.636

3.  Transcriptomic Analysis Identifies RNA Binding Proteins as Putative Regulators of Myelopoiesis and Leukemia.

Authors:  Subha Saha; Krushna Chandra Murmu; Mayukh Biswas; Sohini Chakraborty; Jhinuk Basu; Swati Madhulika; Srinivasa Prasad Kolapalli; Santosh Chauhan; Amitava Sengupta; Punit Prasad
Journal:  Front Oncol       Date:  2019-08-06       Impact factor: 6.244

4.  The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness.

Authors:  Kyumin Kim; Peter Calabrese; Shanshan Wang; Chao Qin; Youliang Rao; Pinghui Feng; Xiaojiang S Chen
Journal:  bioRxiv       Date:  2022-04-07

5.  The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness.

Authors:  Kyumin Kim; Peter Calabrese; Shanshan Wang; Chao Qin; Youliang Rao; Pinghui Feng; Xiaojiang S Chen
Journal:  Res Sq       Date:  2022-04-12

6.  The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness.

Authors:  Kyumin Kim; Peter Calabrese; Shanshan Wang; Chao Qin; Youliang Rao; Pinghui Feng; Xiaojiang S Chen
Journal:  Sci Rep       Date:  2022-09-13       Impact factor: 4.996

7.  The structure of APOBEC1 and insights into its RNA and DNA substrate selectivity.

Authors:  Aaron D Wolfe; Shuxing Li; Cody Goedderz; Xiaojiang S Chen
Journal:  NAR Cancer       Date:  2020-10-09

Review 8.  Insights into the Structures and Multimeric Status of APOBEC Proteins Involved in Viral Restriction and Other Cellular Functions.

Authors:  Xiaojiang S Chen
Journal:  Viruses       Date:  2021-03-17       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.